MALARA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 1.022
EU - Europa 884
AS - Asia 575
OC - Oceania 4
AF - Africa 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.492
Nazione #
US - Stati Uniti d'America 1.008
CN - Cina 505
IE - Irlanda 317
IT - Italia 156
FI - Finlandia 117
DE - Germania 107
UA - Ucraina 62
SE - Svezia 61
SG - Singapore 53
GB - Regno Unito 31
BE - Belgio 17
CA - Canada 13
FR - Francia 8
JP - Giappone 8
CZ - Repubblica Ceca 4
NZ - Nuova Zelanda 4
IN - India 3
MU - Mauritius 3
CL - Cile 2
AM - Armenia 1
BD - Bangladesh 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
HK - Hong Kong 1
IR - Iran 1
NL - Olanda 1
PA - Panama 1
PK - Pakistan 1
PL - Polonia 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 2.492
Città #
Dublin 316
Chandler 242
Nanjing 127
Jacksonville 113
Pavia 80
Beijing 77
Ann Arbor 68
Ashburn 68
Boardman 68
Helsinki 58
Nanchang 57
Shenyang 46
Princeton 43
Lawrence 42
Medford 41
Changsha 37
Wilmington 37
Tianjin 35
Hebei 34
Singapore 34
Shanghai 26
Jiaxing 25
Brussels 17
New York 15
Hangzhou 13
Woodbridge 11
Toronto 10
Falls Church 8
Tokyo 8
Fairfield 7
Los Angeles 7
Milan 7
Falkenstein 6
Jinan 6
Munich 6
Washington 6
Verona 5
Dallas 4
Hamilton 4
Norwalk 4
San Francisco 4
Seattle 4
Fiesole 3
Hanover 3
Leawood 3
Redwood City 3
Augusta 2
Brno 2
Buccinasco 2
Chongqing 2
Clifton 2
Des Moines 2
Guangzhou 2
Olomouc 2
Orange 2
Piscataway 2
Pune 2
Verrua Po 2
Zhengzhou 2
Americana 1
Amsterdam 1
Ardabil 1
Berlin 1
Borås 1
Casorate Sempione 1
Castelli Calepio 1
Castiglione Olona 1
Central 1
Delhi 1
Gallarate 1
Houston 1
Irpin 1
Islamabad 1
London 1
Markham 1
Melilli 1
Menlo Park 1
Missaglia 1
Naples 1
Newark 1
Ningbo 1
Ottawa 1
Padova 1
Palermo 1
Phoenix 1
Piacenza 1
Redmond 1
Rockville 1
Saint Petersburg 1
Sassari 1
Secaucus 1
Shijiazhuang 1
Taizhou 1
Tappahannock 1
Torre del Greco 1
Tradate 1
Turin 1
Venice 1
Vigevano 1
Würzburg 1
Totale 1.905
Nome #
Biocompatibility of functionalized boron phosphate (BPO4) nanoparticles for boron neutron capture therapy (BNCT) application 102
Adhesion to different collagens modulates megakaryocyte development 98
Folic acid-conjugated 4-amino-phenylboronate, a boron-containing compound designed for boron neutron capture therapy, is an unexpected agonist for human neutrophils and platelets 85
The interaction of adenosine diphosphate with P2Y13 regulates in vitro proplatelet formation from human megakaryocytes 84
Megakaryocyte-matrix interaction within bone marrow: new roles for fibronectin and factor XIII-A. 84
Fibronectin and megakaryocyte development 81
Fibronectin Is Dispensable for An Efficient Bone Marrow Thrombopoiesis, but Affects Platelet Size in Mice 77
Extracellular matrix structure and nano-mechanics determine megakaryocyte function 76
BERNARD SOULIER SYNDROME IN A PATIENT AFFECTED BY KLINEFELTER DISEASE: NOVEL A386G HOMOZYGOUS MUTATION OF GPIB alpha GENE WITH ANOMALOUS BEHAVIOUR 76
Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. 73
Outside-in signalling generated by a constitutively activated integrin αIIbβ3 impairs proplatelet formation in human megakaryocytes. 70
The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis control 69
Megakaryocytes Contribute to the Bone Marrow-MatrixEnvironment by Expressing Fibronectin, Type Iv Collagen and Laminin 68
Blood Platelet Production and Morphology. 67
Thrombopoietin/TGF-β1 loop regulates megakaryocyte extracellular matrix component synthesis 67
Thrombopoietin/TGF-β1 Loop Regulates Megakaryocyte Extracellular Matrix Component Synthesis 67
THE D1424N AND R1933X MUTATIONS OF MYH9 CAUSE THROMBOCYTOPENIA THROUGH LOSS OF REGULATION OF PROPLATELET FORMATION BY TYPE I COLLAGEN. 64
Alternatively spliced fibronectin extra domain A is required for hemangiogenic recovery upon bone marrow chemotherapy 63
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatment 62
Hyaluronan based hydrogels provide an improved model to study megakaryocyte-matrix interactions 62
EXTRACELLULAR MATRIX NANO-MECHANICS DETERMINE MEGAKARYOCITE FUNCTION. 59
Extracellular matrix nano-mechanics determines megakaryocyte function 59
Creation and implantation of acellular rat renal ECM-based scaffolds 57
Constitutively released adenosine diphosphate regulates proplatelet formation by human megakaryocytes 57
A A386G biallelic GPIb alpha gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis. 56
The plant hormone abscisic acid is a prosurvival factor in human and murine megakaryocytes 56
Megakaryocytes derived from patients with the classical form of Bernard-Soulier syndrome show no ability to extend proplatelets in vitro. 55
The D1424N and R1933X mutations of MYH9 result in an altered proplatelet formation by human megakaryocytes 55
EDA fibronectin–TLR4 axis sustains megakaryocyte expansion and inflammation in bone marrow fibrosis 55
Brief Report: Alternative Splicing of Extra Domain A (EIIIA) of Fibronectin Plays a Tissue-Specific Role in Hematopoietic Homeostasis 50
EDA Fibronectin-TLR4 Axis Sustains Megakaryocyte Expansion and Inflammation during Bone Marrow Fibrosis Progression. 49
Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies 47
The structure of extracellular matrices influences proplatelet formation by human megakaryocyte 42
New Mechanisms of Megakaryocyte-Matrix Interaction within Bone Marrow Environment 41
Bone marrow microenvironment of MPN cells 39
Mechanisms of platelet release: in vivo studies and in vitro modeling 38
Low penetrance COL5A1 variants in a young patient with intracranial aneurysm and very mild signs of Ehlers-Danlos syndrome 37
Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver 36
Proplatelet formation in heterozygous Bernard-Soulier syndrome type Bolzano. 30
Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation. 27
Sub-Cellular Localization of Metalloproteinases in Megakaryocytes 25
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 24
Elevated plasma EDA fibronectin in primary myelofibrosis is determined by high allele burden of JAK2V617F mutation and strongly predicts splenomegaly progression 23
Bi-allelic variants in the ESAM tight-junction gene cause a neurodevelopmental disorder associated with fetal intracranial hemorrhage 19
Lack of COL6/collagen VI causes megakaryocyte dysfunction by impairing autophagy and inducing apoptosis 18
The α2-adrenergic receptor pathway modulating depression influences the risk of arterial thrombosis associated with BDNFVal66Met polymorphism 17
Inflammation and bone marrow fibrosis: novel immunotherapeutic targets 9
Megakaryocytes in the lung: guests or ghosts? 8
Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis 5
Megakaryocyte Cytoskeletal Proteins in Platelet Biogenesis and Diseases 4
Totale 2.592
Categoria #
all - tutte 11.591
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.591


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020128 0 0 0 0 0 13 11 15 17 49 19 4
2020/2021212 32 12 4 30 1 21 4 29 23 28 23 5
2021/2022264 6 2 4 34 9 8 9 13 15 27 24 113
2022/2023749 84 68 2 60 69 58 3 46 329 8 15 7
2023/2024299 37 62 13 19 20 74 8 22 4 10 13 17
2024/2025170 33 60 14 16 12 35 0 0 0 0 0 0
Totale 2.592